Scientific Sessions 2025  /  Controversies in Lifetime Management of Aortic Stenosis Patients Under 65 years: TAVR vs SAVR First Strategy  /  Is TAVR Increasing in the Young and What are the Outcomes?
Logo

American Heart Association

  58
  0

Final ID:

Is TAVR Increasing in the Young and What are the Outcomes?

  • Forcillo, Jessica  ( University of Montreal , Montreal , Quebec , Canada )
  • Eltchaninoff, Helene  ( Rouen University Hospital , Rouen , France )
  • Preventza, Ourania  ( University of Virginia , Houston , Texas , United States )
  • Ouzounian, Maral  ( Toronto General Hospital , Toronto , Ontario , Canada )
    • Author Disclosures:
    Jessica Forcillo: DO NOT have relevant financial relationships | Helene Eltchaninoff: No Answer | Ourania Preventza: DO have relevant financial relationships ; Consultant:Intressa Vascular :Active (exists now) ; Consultant:AbioMed:Past (completed) ; Consultant:Terumo Aortic :Active (exists now) ; Consultant:Artivion:Active (exists now) ; Consultant:Gore and Associates :Active (exists now) | Maral Ouzounian: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Controversies in Lifetime Management of Aortic Stenosis Patients Under 65 years: TAVR vs SAVR First Strategy

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Bigger is Better: Bioprosthetic Surgical Aortic Valve with Y-Root Enlargement

Yang Bo, Kim Karen, Hamilton Barbara, Boskovski Marko

Redo TAVR in TAVR vs Need for TAVR Explantation

Kaneko Tsuyoshi, Fukuhara Shinichi, Bapat Vinayak, Arnaoutakis George, Ouzounian Maral

More abstracts from these authors:
One and Done: Mechanical SAVR for Lifetime Management

Preventza Ourania, Goldstone Andrew, Bowdish Michael, Ouzounian Maral, Woo Y Joseph, Chikwe Joanna, Forcillo Jessica

Panel

Ouzounian Maral, Forcillo Jessica

You have to be authorized to contact abstract author. Please, Login
Not Available